TLR7 and psoriasis: Consequently, SHP2‐mediated TLR7/NF‐κB activation was augmented, leading to further increases in the expressions of psoriasis‐related inflammatory cytokines, including IL‐23A, TNF‐α, IL‐6, and IL‐1β, thus accelerating psoriasis‐like skin inflammation.